How many insider trades does FilingIQ track for EXAS?

FilingIQ tracks 1,228 Form 4 insider transactions for EXAS (EXACT SCIENCES CORP), covering filings from Jun 2, 2001 onwards. 83 of those were filed in the last 90 days.

Are EXAS insiders net buyers or net sellers?

Across the full Form 4 history for EXAS, 5 transactions (0%) were open-market purchases and 433 (35%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does EXAS insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is EXAS in?

EXACT SCIENCES CORP (EXAS) is classified in the Healthcare sector, specifically Diagnostics & Research, with a current market capitalisation of $19.77B.

EXAS insider trading

NasdaqCM Healthcare

EXACT SCIENCES CORP — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

1,228

Last 90 days

Buys / sells

0% / 35%

Market cap

$19.77B

About EXACT SCIENCES CORP

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer; Cologuard Plus Tests; Cancerguard Test; and Genetic Testing. The company also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; Oncodetect Test;OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Riskguard Test, a hereditary cancer test to understand their inherited risk of cancer. Its pipeline focus on advancing screening and diagnostic products, including risk assessment, screening and prevention, early disease diagnosis, adjuvant and/or neoadjuvant disease treatment, metastatic disease treatment selection, and recurrence monitoring. The company has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University, as well as Freenome Holdings, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

Company website: www.exactsciences.com

EXAS insider activity at a glance

FilingIQ has scored 1,228 insider transactions for EXAS since Jun 2, 2001. The most recent filing in our index is dated Mar 23, 2026.

Across the full history, 5 open-market purchases and 433 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on EXAS insider trades is 63.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live EXAS trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding EXAS

EVENTIDE ASSET MANAGEMENT, LLC

$80.14M · 1.3% of AUM

Laurion Capital Management LP

$50.73M · 1.9% of AUM

Casdin Capital, LLC

$27.46M · 2.1% of AUM

READYSTATE ASSET MANAGEMENT LP

$21.15M · 0.7% of AUM

Frequently asked

How many insider trades does FilingIQ track for EXAS?: FilingIQ tracks 1,228 Form 4 insider transactions for EXAS (EXACT SCIENCES CORP), covering filings from Jun 2, 2001 onwards. 83 of those were filed in the last 90 days.
Are EXAS insiders net buyers or net sellers?: Across the full Form 4 history for EXAS, 5 transactions (0%) were open-market purchases and 433 (35%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does EXAS insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is EXAS in?: EXACT SCIENCES CORP (EXAS) is classified in the Healthcare sector, specifically Diagnostics & Research, with a current market capitalisation of $19.77B.

Methodology & sources

Every EXAS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.